Capital International Inc’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-398
Closed -$223K 295
2020
Q4
$223K Buy
398
+14
+4% +$8.87K ﹤0.01% 290
2020
Q3
$269K Buy
384
+54
+16% +$42.1K ﹤0.01% 272
2020
Q2
$261K Buy
330
+225
+214% +$170K ﹤0.01% 258
2020
Q1
$63K Sell
105
-937
-90% -$913K ﹤0.01% 258
2019
Q4
$1.18M Sell
1,042
-27,478
-96% -$29.9M 0.02% 182
2019
Q3
$33.9M Buy
28,520
+25,690
+908% +$39.2M 0.51% 86
2019
Q2
$4.66M Buy
2,830
+973
+52% +$1.68M 0.33% 82
2019
Q1
$3.78M Buy
1,857
+210
+13% +$370K 0.45% 49
2018
Q4
$2.12M Sell
1,647
-50
-3% -$76.7K 0.29% 77
2018
Q3
$3.21M Buy
1,697
+479
+39% +$990K 0.42% 64
2018
Q2
$2.48M Buy
1,218
+209
+21% +$476K 0.38% 60
2018
Q1
$2.23M Buy
+1,009
New +$2.57M 0.32% 66

Other funds holding BLUE

Capital International Inc's BLUE Position: Q1 2021 in Review

Capital International Inc sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 398 shares — an estimated $223K sold.

Capital International Inc first reported a position in BLUE in Q1 2018 and held it in 12 quarters. The position peaked at $33.9M in Q3 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Capital International Inc reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Capital International Inc sold 398 bluebird bio shares in Q1 2021, an estimated $223K.
  • Capital International Inc first reported a position in bluebird bio in Q1 2018 and held it in 12 quarters.
  • Capital International Inc's bluebird bio position peaked at $33.9M in Q3 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Capital International Inc's 13F filing for Q1 2021, filed 14 May 2021.